SPY345.24+1.86 0.54%
DIA284.00+1.05 0.37%
IXIC11,607.18+90.69 0.79%

Citigroup Initiates Coverage On Arcturus Therapeutics with Buy Rating, Announces Price Target of $65

Citigroup analyst Yigal Nochomovitz initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces Price Target of $65.

· 10/06/2020 07:27
Citigroup analyst Yigal Nochomovitz initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces Price Target of $65.